An analysis of risks and benefits of drugs in specific types of patients will help rheumatologists provide better treatment
California Rheumatology Alliance 2013 Meeting: The Future of Rheumatoid Arthritis
Treatment for RA should involve targeting subclinical disease and reversing immune dysregulation, expert says
What Rheumatologists Need to Know About the Physician Payment Sunshine Act
The federal act mandates transparency within physician–industry relationship
Researchers Explore HLA-B27’s Role in the Development of Spondylitis
New research reports on the increased sensitivity of human-HLA-B27 transgenic rat bone marrow monocytes to TNF-α stimulation and osteoclast differentiation. (posted June 27, 2013)
Can Lubricating Joints Prevent Osteoarthritis?
Proteoglycan 4 (Prg4), also known as lubricin, could slow the process of cartilage destruction in osteoarthritis. (posted June 13, 2013)
Small Fiber Function May Be Linked to Fibromyalgia
Researchers show, for the first time, that small fiber function and morphology is impaired in patients with fibromyalgia. (posted June 18, 2013)
Th17 May Contribute to Bone Destruction by Modifying Osteoclasts
New research describes the role of RANKL-expressing Th17 cells in inflammatory bone destruction. (posted June 3, 2013)
Advances in Genomics, Bioinformatics Draw New Insights From the Human Genome
Widely held belief that large segments of the human genome consist of ‘junk DNA’ is incorrect, say scientists
Apply to Attend the ACR’s Advocates for Arthritis Day
Event educates legislators about the impact of rheumatic diseases and the importance of care provided by rheumatology professionals
Arthritis Care & Research Celebrates 25 Years
From its beginnings as a quarterly journal in 1988, to a successful monthly publication today, AC&R has evolved and thrived
- « Previous Page
- 1
- …
- 232
- 233
- 234
- 235
- 236
- …
- 300
- Next Page »